Effects of Hypochlorhydria and Hypergastrinemia on Structure and Function of Gastrointestinal Cells. A Review and Analysis
Overview
Authors
Affiliations
Since hypochlorhydria can induce hypergastrinemia, and gastrin has a trophic effect on some gastrointestinal cells, states that cause elevated plasma gastrin levels are of interest in terms of effects on cell growth and function. This article reviews the relationship between gastric mucosal cells during periods of acid stimulation and inhibition and analyses the effects of hypochlorhydria and hypergastrinemia on gastric and colonic cells and tumors. Hypochlorhydria releases the inhibitory effect of antral gastrin cells, inducing them to release gastrin in the presence of peptides or amino acids in the gastric lumen or in response to antral distension. Gastrin stimulates the oxyntic mucosa, which may lead to hyperplasia of enterochromaffin-like cells, resulting in enterochromaffin-like carcinoid tumors in aged rats and, rarely, in patients with chronic atrophic gastritis or gastrinomas. In addition to hypergastrinemia, other factors appear to be required for the progression of enterochromaffin-like hyperplasia to carcinoids; genetic factors may be involved. Gastrin elevations due to antisecretory drug therapy are indirectly proportional to the degree of acid inhibition and are reversible upon cessation of therapy. The gastrin levels during omeprazole therapy are similar to those caused by gastric vagotomy. Available evidence does not support a relationship between hypergastrinemia and the occurrence or growth of gastric carcinoma or colonic tumors.
Personalizing protein nourishment.
Dallas D, Sanctuary M, Qu Y, Haghighat Khajavi S, Van Zandt A, Dyandra M Crit Rev Food Sci Nutr. 2015; 57(15):3313-3331.
PMID: 26713355 PMC: 4927412. DOI: 10.1080/10408398.2015.1117412.
Long-term proton pump inhibitor use in children: a retrospective review of safety.
Tolia V, Boyer K Dig Dis Sci. 2007; 53(2):385-93.
PMID: 17676398 DOI: 10.1007/s10620-007-9880-7.
Multifocal gastric carcinoid tumor in a patient with pernicious anemia receiving lansoprazole.
Attila T, Santharam R, Blom D, Komorowski R, Koch T Dig Dis Sci. 2005; 50(3):509-13.
PMID: 15810634 DOI: 10.1007/s10620-005-2466-3.
Gold B, Freston J Paediatr Drugs. 2002; 4(10):673-85.
PMID: 12269842 DOI: 10.2165/00128072-200204100-00004.
Singh P, Indaram A, Greenberg R, Visvalingam V, Bank S World J Gastroenterol. 2002; 6(6):789-792.
PMID: 11819697 PMC: 4728264. DOI: 10.3748/wjg.v6.i6.789.